Evidence map›Paper›PMID 41555473›Full record

ArticleJournal of anesthesia, analgesia and critical care2026

Epidemiology and outcome of intra-abdominal infections in intensive care unit in Italy from the Italian Register of complicated Intra-abdominal InfectionS-the IRIS study: a prospective observational nationwide study.

Etrusca Brogi, Camilla Cremonini, Marco Ceresoli, Fausto Catena, Angela Gurrado, Francesco Forfori, Lorenzo Ghiadoni, Ettore Melai, IRIS study group, Massimo Sartelli and 1 more

Abstract read
In one paragraph

Article in Journal of anesthesia, analgesia and critical care, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Deciphering the Implications ofPathogens (Basel, Switzerland) · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Etrusca BrogiDepartment of Anaesthesia and Intensive Care, Pisa University Hospital, Pisa, Italy. etrusca.brogi@ospedaleniguarda.it.
Camilla CremoniniGeneral, Emergency and Trauma Surgery Deparment, Pisa University Hospital, Pisa, Italy. c.cremonini89@gmail.com.
Marco CeresoliGeneral Surgery Deparment, Milano Bicocca University Hospital, Monza, Italy.
Fausto CatenaGeneral, Emergency and Trauma Surgery Deparment, Bufalini Hospital, Cesena, Italy.
Angela GurradoGeneral Surgery, Bari University Hospital, Bari, Italy.
Francesco ForforiDepartment of Anaesthesia and Intensive Care, Pisa University Hospital, Pisa, Italy.
Lorenzo GhiadoniEmergency Medicine Deparment, Pisa University Hospital, Pisa, Italy.
Ettore MelaiDepartment of Anaesthesia and Intensive Care, Pisa University Hospital, Pisa, Italy.
IRIS study group
Massimo SartelliGeneral Surgery Deparment, Macerata Hospital, Macerata, Italy.
Federico CoccoliniGeneral, Emergency and Trauma Surgery Deparment, Pisa University Hospital, Pisa, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIntra-abdominal infections are complex and potentially life-threatening conditions frequently requiring intensive care admission and are associated with highly variable mortality driven by disease severity, host response, comorbidities, and antimicrobial resistance. Outcomes depend on timely diagnosis, effective surgical source control, appropriate antimicrobial therapy, and a coordinated multidisciplinary approach addressing both the infectious and systemic inflammatory components of the disease. MATERIAL AND

methodThis was a prospective, observational nationwide study. We included all adult patients admitted to the hospital with complicated abdominal infections requiring ICU admission. The aim of this study was to describe the epidemiology and outcomes of patients admitted to the hospital with intra-abdominal infections (IAIs) requiring an intensive care unit (ICU) admission in 23 Italian hospitals.

resultsA total of 784 patients admitted to the hospital with complicated IAIs requiring ICU admission were enrolled. Overall, in-hospital mortality among ICU patients was 23.9%. Septic shock (36.2%) and sepsis (35.9%) were the main reasons for ICU admission. Community-acquired infections accounted for 64.8% of cases, and adequate source control was achieved in 61.5% of patients. Re-operation was required in 21%. The most frequently isolated pathogens were Escherichia coli (23.1%), followed by Enterococcus spp. (15.4%). Empiric antibiotic therapy was prescribed in more than 80% of patients (median duration ranging from 8.1 to 19.3 days). Piperacillin-tazobactam was the most commonly used antibiotic. In multivariable logistic regression analysis, increasing age (OR 1.04 per year, 95% CI 1.03-1.06), immunosuppression (OR 1.99, 95% CI 1.09-3.66), serious cardiovascular disease (OR 1.91, 95% CI 1.20-3.05), re-operation (OR 2.30, 95% CI 1.34-3.96), inadequate source control (OR 0.39, 95% CI 0.22-0.71), peritonitis (OR 0.39, 95% CI 0.23-0.66), and healthcare-associated infections (OR 1.83, 95% CI 1.10-3.04) were independently associated with in-hospital mortality. Duration of antibiotic therapy, malignancy, and delay in initial intervention were not significantly associated with mortality.

conclusionSeptic shock remains the leading cause of ICU admission in patients with IAIs. Patients with immunosuppression, serious cardiovascular comorbidities, requirement for re-operation, inadequate source control, peritonitis, and healthcare-associated infections were at significantly higher risk of in-hospital mortality. Overall, our study reinforces the multifactorial nature of mortality in critically ill patients with intra-abdominal infections, highlighting modifiable factors (source control, timely intervention) that can be targeted to improve outcomes.

Indexed as

Antibiotic therapyEpidemiologyIntensive care unitIntra-abdominal infectionsOutcomePrognosisSurgery

Identifiers

PMID41555473
PMCPMC12903239

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.